Who are SRP + Injectable Platelet-Rich Fibrin's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/srp-injectable-platelet-rich-fibrin.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

SRP + Injectable Platelet-Rich Fibrin — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SRP + Injectable Platelet-Rich Fibrin (SRP + Injectable Platelet-Rich Fibrin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Regenerative medicine / Periodontal therapy. Area: Dentistry / Periodontics.

marketed Regenerative medicine / Periodontal therapy Dentistry / Periodontics Small molecule Live · refreshed every 30 min

Target snapshot

SRP + Injectable Platelet-Rich Fibrin (SRP + Injectable Platelet-Rich Fibrin) — University of Belgrade. SRP (Scaling and Root Planing) combined with Injectable Platelet-Rich Fibrin promotes periodontal tissue regeneration and healing by delivering concentrated growth factors and platelets to diseased periodontal sites.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
SRP + Injectable Platelet-Rich Fibrin TARGET	SRP + Injectable Platelet-Rich Fibrin	University of Belgrade	marketed	Regenerative medicine / Periodontal therapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Regenerative medicine / Periodontal therapy class)

University of Belgrade · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SRP + Injectable Platelet-Rich Fibrin — Competitive Intelligence Brief. https://druglandscape.com/ci/srp-injectable-platelet-rich-fibrin. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab